AI is already changing the world, and the scale of that change is accelerating. The practical question isn’t whether it will happen but how deeply it reshapes work, medicine, science, and daily life over the next decade. The Penn Wharton Budget Model estimates AI will increase global productivity and GDP by 1.5% by 2035, nearly 3% by 2055, and 3.7% by 2075. Those numbers sound modest until you realize they represent trillions of dollars in cumulative economic output.
The Economic Shift
AI’s economic impact works primarily through productivity. Software that can draft documents, write code, analyze data, and handle customer interactions allows fewer people to produce more output. That productivity gain compounds over time, which is why the projected GDP boost roughly doubles between 2035 and 2055. In the United States alone, preliminary analysis suggests AI could reduce federal budget deficits by $400 billion over the ten-year window between 2026 and 2035, largely through efficiency gains in government operations and stronger tax revenue from a more productive economy.
The labor market story is more complicated than “robots take all the jobs.” Every wave of automation in history has eliminated certain roles while creating others that didn’t previously exist. AI follows this pattern but moves faster. Routine cognitive work (data entry, basic analysis, first-draft writing, customer service scripting) is already being absorbed by AI tools. The new roles tend to involve managing, training, auditing, or building on top of AI systems. The friction comes in the transition: the people whose jobs shrink aren’t always the same people who fill the new positions, and retraining takes time.
Medicine and Drug Discovery
Healthcare may be where AI’s impact feels most tangible. Developing a new drug traditionally takes 10 to 15 years from initial discovery to regulatory approval, at a cost that often exceeds $1 to $2 billion. AI is compressing that timeline dramatically. Insilico Medicine identified a novel target for a serious lung disease called idiopathic pulmonary fibrosis and advanced a drug candidate into preclinical trials in just 18 months, a process that typically takes four to six years, at a fraction of the usual cost. Another company, Exscientia, developed a drug candidate for obsessive-compulsive disorder in under 12 months, making it the first AI-designed molecule to enter human clinical trials.
These aren’t isolated cases. A systematic review of 173 studies found that every single one demonstrated some form of timeline acceleration when AI was integrated into the drug development pipeline. The preclinical phase, which traditionally stretches over several years, can potentially be compressed to a few months by using AI to process genomic, protein, and chemical data simultaneously rather than sequentially. Faster drug development doesn’t just save money. It means treatments for diseases like cancer, Alzheimer’s, and rare genetic conditions could reach patients years earlier than they otherwise would.
AI is also changing how diseases get detected. In lung cancer screening, a deep learning model outperformed expert radiologists, achieving a diagnostic accuracy score of 0.94 compared to 0.88 for human specialists. The AI reduced false positives (cases flagged as cancer that aren’t) while maintaining the same rate of true positives, and it identified malignancies earlier. This kind of improvement, applied across radiology, pathology, and cardiology, could catch diseases at stages where they’re far more treatable.
Scientific Breakthroughs
Beyond medicine, AI is solving problems that stumped scientists for decades. AlphaFold, developed by Google’s DeepMind, cracked the protein folding problem, predicting the three-dimensional shapes of proteins from their genetic sequences. Understanding protein structure is fundamental to biology. It determines how diseases work, how drugs bind to their targets, and how organisms function at a molecular level. Scientists had been trying to solve this computationally since the 1970s.
AlphaFold has since predicted protein structures across entire genomes, including human, mouse, yeast, and bacterial genomes, effectively giving researchers a detailed molecular atlas that would have taken experimental biologists decades to build. It’s been called the most groundbreaking application of AI in science to date, and its predictions are already being used to accelerate drug discovery, understand disease mechanisms, and engineer new biological materials.
AI in Everyday Life
For most people, AI’s world-changing effects will show up in how they interact with technology day to day. AI agents are moving beyond answering questions into performing real-world tasks. Agentic browsers can now navigate websites, fill out forms, and complete transactions on your behalf rather than simply displaying web pages for you to click through. OpenAI and the payment company Stripe have built protocols that let AI agents make purchases inside a chat window, turning conversational AI into something that can actually buy things for you.
Open-source AI agents already exist that run on your personal computer, control your browser and files, and communicate with you through messaging apps like WhatsApp. These tools are early and sometimes clunky, but they point toward a near future where your AI assistant doesn’t just suggest a restaurant but books the table, adjusts your calendar, and orders a car to get you there. Companies across food delivery, travel, and e-commerce are building this kind of autonomous capability into their platforms right now.
The Environmental Cost
AI’s expansion comes with a significant energy bill. Global electricity consumption by data centers reached 460 terawatt-hours in 2022. By 2026, that figure is expected to approach 1,050 terawatt-hours, more than doubling in just four years. To put that in perspective, data centers would then consume more electricity than Japan, making them the fifth-largest electricity consumer on Earth if they were a country. Training large AI models is especially power-hungry, and as models grow more capable, their energy demands tend to grow with them.
This creates a real tension. AI tools can help optimize energy grids, reduce waste in manufacturing, and improve climate modeling. But the infrastructure required to run those tools is itself a major and growing source of carbon emissions, particularly in regions where the electrical grid still relies heavily on fossil fuels. How quickly data centers shift to renewable energy will determine whether AI ends up helping or hurting on the climate front.
Regulation Is Playing Catch-Up
Governments are scrambling to set rules for a technology that evolves faster than legislation. The European Union’s AI Act is the most comprehensive attempt so far. Its general provisions, including definitions and requirements for AI literacy, took effect in February 2025. The majority of the law’s rules, along with active enforcement at both national and EU levels, kick in on August 2, 2026. The Act categorizes AI systems by risk level, banning certain practices outright (like social scoring by governments) while imposing strict requirements on high-risk applications in areas like hiring, law enforcement, and healthcare.
Other countries are taking different approaches. The U.S. has relied more on executive orders and sector-specific guidance than comprehensive legislation. China has implemented its own AI regulations focused on generative content and algorithmic recommendations. The lack of global coordination means companies building AI tools face a patchwork of rules depending on where they operate, and people in different countries will have very different levels of protection from AI-related harms like biased decision-making or invasive surveillance.
The scale and speed of AI’s integration into the economy, healthcare, science, and daily routines make it one of the most consequential technologies since electricity or the internet. Whether it changes the world for the better depends heavily on how its benefits are distributed, how its environmental costs are managed, and whether regulation can keep pace with capabilities that show no sign of slowing down.